T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro-Reference-Cited by-同舟云学术

T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro

Published:2012-05 Issue:1 Volume:13 Page:54-60
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Du Fang,Lü Liang-jing,Teng Jia-lin,Shen Nan,Ye Ping,Bao Chun-de

Funder

National Natural Science Foundation of China

Specialized Research Fund for the Doctor Program of Higher Education

Shanghai Key Discipline Construction Project

Shanghai Hospital Clinical and Research Resource Platform Project

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference28 articles.

1. The immunology of rheumatoid arthritis;Scrivo;Ann N Y Acad Sci,2007

2. Cells of the synovium in rheumatoid arthritis. Dendritic cells;Lutzky;Arthritis Res Ther,2007

3. Role of GADD45 beta in the regulation of synovial fluid T cell apoptosis in rheumatoid arthritis;Du;Clin Immunol,2008

4. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors;Firestein;Arthritis Rheum,1996

5. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis;Pap;Arthritis Rheum,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electroacupuncture Ameliorates Knee Osteoarthritis By Rebalancing T Cell Homeostasis as Revealed By Immune Repertoire (IR) Sequencing;Combinatorial Chemistry & High Throughput Screening;2024-08-12

2. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis;Biomedicine & Pharmacotherapy;2024-05

3. Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases;Frontiers in Immunology;2023-09-21

4. Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression;Arthritis Research & Therapy;2023-08-18

5. Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials;Frontiers in Immunology;2023-03-03